Single-center study reports ten-year outcomes of hybrid coronary revascularization in multi-vessel coronary disease, highlighting the importance of surgical and percutaneous procedure timing.
Hybrid coronary revascularization (HCR) is a well-established technique for treating multi-vessel coronary disease. There remains a paucity of discussion assessing the efficacy of HCR with respect to the timing of the surgical component relative to that of the percutaneous coronary intervention (PCI).
No takes yet. Share an insight, caveat, or question.
Newman et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: